← FDA Drug Approvals (Drugs@FDA)
AFATINIB DIMALEATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2026-07-14
Drug application
- FDA Application #
ANDA210725- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AFATINIB DIMALEATE
- Generic name
- Afatinib Dimaleate
- Active ingredients
- AFATINIB DIMALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APOTEX
- First approval
- 2026-07-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown